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ABSTRACT: Magnetic nanoparticles have been proposed as interesting tools for biomedical 
purposes. One of their promising utilization is the MRI in which magnetic substances like 
maghemite are used in a nanometric size and encapsulated within locally biodegradable 
nanoparticles. In this work, maghemite has been obtained by a modified sol-gel method and 
encapsulated in polymer-based nanospheres. The nanospheres have been prepared by single 
emulsion evaporation method. The different parameters influencing the size, polydispersity index 
and zeta potential surface of nanospheres were investigated. The size of nanospheres was found 
to increase as the concentration of PLGA increases, but lower sizes were obtained for 3 min of 
sonication time and surfactant concentration of 1%. Zeta potential response of magnetic 
nanospheres towards pH variation was similar to that of maghemite-free nanospheres confirming 
the encapsulation of maghemite within PLGA nanospheres. The maghemite entrapment 
efficiency and maghemite content for nanospheres are 12% and 0.59% w/w respectively. 
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1. INTRODUCTION 
Magnetic nanoparticles (MNPs) have attracted much attention in the last decades for their 
potential applications in materials science or/and biomedicine. More particularly, due to 
magnetic properties, this kind of nanoparticles can be used in various special medical techniques 
such as drug targeting, magnetic resonance imaging (MRI) and magnetic fluid hyperthermia 
(MFH). 1, 2 
In the last decade, increased investigations with several types of iron oxides have been carried 
out in the field of MNPs. Thus, the following iron compounds have been proposed to produce 
MNPs: Fe3O4 or magnetite (FeIIFeIII2O4), Į-Fe2O3 (hematite), Ȗ-Fe2O3 (maghemite), FeO 
(wustite), İ-Fe2O3 and ȕ-Fe2O3. Among them, MNPs from either magnetite or maghemite are the 
most promising and popular candidates for biological purposes since their biocompatibility have 
already been proven. Both types of ferromagnetic nanoparticles may be also superparamagnetic 
when their size is below 15 nm. 3 
One of the most researched biomedical applications for MNPs is hyperthermia. It has been 
used as alternative cancer therapy to minimize severe adverse effects of conventional treatments. 
Hyperthermia of tumors can be achieved using different strategies, such as application of 
microwave and radio frequency fields or introduction of ferromagnetic needles in the cancer site. 
Although hyperthermia has been shown to be an extremely powerful anti-cancer agent and a 
potent radiation sensitizer, the full potential of this therapy is hindered by a number of 
limitations, as for instance the non-homogeneous distribution of temperature over the cancer site, 
low specificity, patient discomfort, and thermo-tolerance development. 4 More recently, in order 
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to overcome the above-mentioned limitations, biocompatible magnetic nanoparticles have been 
proposed as a material basis to support the development of hyperthermia. 5 For MNPs based 
hyperthermia, a general procedure involves the distribution of particles throughout the targeted 
tumor site followed by generation of heat in to the tumor using an applied magnetic field. 6 7 The 
mechanism of heating can be attributed to the phenomena of relaxation (Néel and Brownian) and 
hysteresis loss. 8  
In spite of their high hyperthermia efficiency, many MNPs show some drawbacks that may 
limit their potential use. These inconveniences are related with their large surface-to-volume 
ratio and, indeed, high surface energies. Consequently, these nanoparticles tend to aggregate in 
order to minimize their surface energies. Moreover, the naked iron oxide nanoparticles have high 
chemical activity, and are easily oxidized in air, resulting in loss of magnetism and dispersibility 
properties. One possible strategy to minimize these drawbacks may be to coat or encapsulate 
MNPs in polymeric nanospheres and nanocapsules made from biodegradable polymers. These 
polymers would act as protecting shells, stabilizing the MNPs and, eventually, may be used for 
further functionalization. In addition, the adequate selection of the coating polymer may permit 
to prolong the circulation time of the composite and, then, increase the possibilities to MNPs to 
reach and concentrate in the tumor area. 9  
In this context, synthetic and natural polymers have been extensively researched for the 
stabilization and functionalization of MNPs. 10 Usually synthetic polymers are preferred because 
of their purity and reproducibility. Among others, copolymers between lactic and glycolic acids 
[poly(lactide-co-glycolide) (PLGA)] offer additional advantages such as their biocompatibility 
and biodegradability to nontoxic metabolites as well as their approval by regulatory agencies (i.e. 
FDA) for human therapeutic uses. 11  
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However, a challenge on the coating of MNPs by polymers is the incompatibility between 
magnetic particles and PLGA and other biocompatible polymers is that the hydrophobic nature 
of these compounds hampers the encapsulation of MNPs. In fact, the main problem is how to 
incorporate, in a high extent, MNPs into PLGA particulates in order to obtain a system capable 
to be used for hyperthermia purposes. 12 Most studies used iron oxides coated with oleic acid in 
order to make the surface hydrophobic and thus more compatible with PLGA. 13- 15 Although 
oleic acid has been recognized as an unsaturated fatty acid with numerous benefits to human 
health, currently, some articles has been questioning possible risks that this fatty acid may lead to 
the human body. 16  The findings suggest that exposure of low concentrations of oleic 
acid negatively affects the barrier function of the intestinal epithelium, including mechanisms 
that prevent absorption of potentially toxic substances common in food. 17- 19 
Because of this, the challenge of this study was to develop a procedure to entrap iron oxide 
magnetic nanoparticles in PLGA nanospheres in the absence of toxic or irritant compounds (i.e. 
oleic acid). In addition we have focused our study on the optimization of nanospheres and 
nanocapsules production. In particular, the effects of sonication time, surfactant, polymer and 
iron oxide amount have been investigated with respect to their impact on the physico-chemical 
characteristics of the resulting MNPs-loaded PLGA nanospheres. 
2. EXPERIMENTAL 
2.1 Materials 
Ferric nitrate (Fe(NO3)3.9H2O) (Vetec, Brazil), poly(vinyl alcohol) (PVA; MW 146,000-180,000 
88-89% hydrolyzed) (Aldrich,USA) , Pluronic F-68 (Sigma-Aldrich, USA), Poly-lactic-co-
glycolic acid with a monomer ratio of 50:50 (Resomer® RG 502, Boehringer Ingelheim, 
 5
Germany), ethyl acetate (99%- Panreac, Spain), dichlorometane (99%, Merck, Germany) sodium 
citrate tribasic dehydrate (ACS 99%- Sigma Aldrich, USA), sucrose (Fragon, Spain). 
2.2 Synthesis of maghemite nanoparticles (Mag)  
The maghemite nanoparticles (Mag) were synthetized by a modified sol-gel method.20 
Aqueous diluted PVA (10% w/v) and saturated ferric nitrate solutions were separately prepared 
and then mixed at specific metallic ion/monomer unit ratios. The solutions were maintained at 
room temperature under stirring for 2 h and then heated under vigorous stirring until total water 
evaporation. The temperature was maintained at 150°C for thermal degradation of the polymer. 
The nanostructured material was obtained after calcination of the material under air atmosphere 
at 400°C for 4h. 
2.3 Preparation of maghemite loaded-PLGA nanospheres (MagPLGA-NE) 
PLGA nanospheres loaded with Mag were prepared by a single emulsion method previously 
described.21 For this purpose, Mag was dispersed by sonication (Microson ultrasonic cell 
disruptor XL, Misonix, USA) in 0.5 ml of ethyl acetate for 1 min. This suspension was then 
mixed with a solution of PLGA in the same solvent. The organic phase was then emulsified by 
sonication in 3 mL of an aqueous solution of PVA. The resulting suspensions were stirred with a 
blade stirrer at room temperature in order to eliminate the organic solvent. The resulting 
nanoparticles were, firstly, centrifuged at 1,000 rpm for 20 min in order to eliminate unloaded 
Mag and, secondly, were washed two times with distilled water by consecutive centrifugation 
(Biofuge Stratus, Heraeus Instruments, Germany) at 17,000 r.p.m. for 10 min at 4ºC.  The pellet 
was then dispersed in 3 ml aqueous solution containing 5% sucrose as cryoprotector. The 
formulations were freeze-dried in a Genesis 12EL apparatus (Virtis, USA). Empty PLGA 
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nanospheres (PLGA-NE) were prepared as described above without using Mag and used as 
control. 
2.4 Physico-chemical characterization 
X-ray measurements were carried out on a Siemens-5000 powder diffractometer with 
monochromated Cu KĮ1 radiation (Ȝ=1.54056Å ). Reflection x-ray powder diffraction data were 
collected from 10° to 90° in 2h.  The size of maghemite nanoparticles was calculated based on 
the full-width at half maximum of (220) preferred orientation using the Scherrer equation 
(equation 1):  22 
݀ ൌ ௄ఒሺ஻௖௢௦ఏಳሻ   (1) 
where Ȝ is the X-ray wavelength, ț the shape factor, D the average diameter of the crystals, șB 
the Bragg angle, and B is the line broadening measured at half-height.  
The value of ț depends on several factors, including the Miller index of the reﬂecting plane 
and the shape of the crystal. If the shape is unknown, ț is often assigned a value of 0.89 
FTIR spectra were obtained using a FTIR BOMEM MB 100 spectrometer (Quebec, Canada) 
with samples in 1% KBr pellets, operating from 4000 to 400 cmí1, at resolution of 4 cmí1. 
The size and zeta potential of Mag nanoparticles and Mag-loaded PLGA nanospheres were 
determined by photon correlation spectroscopy and electrophoretic laser Doppler anemometry, 
respectively, using a Zetamaster analyzer system (Malvern Instruments, UK). For size 
measurements, samples were dispersed with deionized water and measured at 25 °C with a 
scattering angle of 90° and for zeta potential measurements, samples were dispersed in aqueous 
solution of KCl 0.3mM at pH 3-10. The mean hydrodynamic diameter was obtained by fitting 
the autocorrelation function with the cumulant method, which also gives the polydispersity index 
(PDI) (equation 2), which is defined as: 23 
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ܲܦܫ ൌ ோ೔షభோ೔శభሺோ೔ሻమ  (2) 
where Ri is the ith moment of the particle size distribution.  
For average diameter measurements the error bar indicates the width of the distribution and for 
the PDI measurements the error bar indicates the standard deviation calculated from three 
measurements. 
The shape and morphology of nanoparticles and nanospheres were assessed by electron 
microscopy. Mag nanoparticles were observed by TEM in a JEM-1400 apparatus (JEOL, Tokyo, 
Japan). For this purpose, samples were diluted with methanol and placed on a formvar/Carbon 
400 mesh, copper grid (Tedpella) without any staining. Then the drops were dried at room 
temperature and visualized in the apparatus. For Mag-loaded PLGA nanospheres, they were 
negatively stained with phosphotungstic acid before observation in the TEM apparatus (EM10, 
Zeiss, USA) after negative staining of the samples with phosphotungstic acid. On the other hand, 
particles were also examined by using a Field Emission Scanning Electron Microscope (Carl 
Zeiss Ultra Plus, Germany). In this case, samples were mounted on Carbon coated TEM copper 
grids (carbon films on 3mm 400 mesh grids, Agar Scientific) and placed in a desiccator in order 
to evaporate water. Finally, the grids were adhered with a double-sided adhesive tape onto metal 
stubs for SEM visualization. 
2.5 Amount of Mag-loaded in nanospheres  
To determine the amount of maghemite nanoparticles encapsulated in the PLGA composites, 
20 mg of Mag-loaded PLGA nanospheres were digested in 20 mL HCl 18.5% during 2 h at 70ºC. 
The resulting mixtures were diluted in distilled water and the iron concentration in samples was 
quantified by atomic absorption spectrophotometry (AAS) at 248.4 nm using acetylene-air flame 
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in a Varian AA10 plus apparatus (Varian, Australia). The assay was linear between 0 and 
8 ȝg/ml with a correlation coefﬁcient of 1.0 
Loaded maghemite in optimized MagPLGA nanospheres were calculated from the amount of 
iron measured by AAS. Maghemite entrapment efficiency (%) and maghemite content (% w/w) 
were calculated by equations 3 and 4, respectively: 
Maghemite entrapment efficiency (%): 
ൌ ெ௔௦௦௢௙௠௔௚௛௘௠௜௧௘௜௡ெ௔௚௉௅ீ஺௡௔௡௢௦௣௛௘௥௘௦ெ௔௦௦௢௙௠௔௚௛௘௠௜௧௘௨௦௘ௗ௜௡௙௢௥௠௨௟௔௧௜௢௡                 (3) 
Maghemite content (% w/w): 
ൌ ெ௔௦௦௢௙௠௔௚௛௘௠௜௧௘௜௡ெ௔௚௉௅ீ஺௡௔௡௢௦௣௛௘௥௘௦ெ௔௦௦௢௙ெ௔௚௉௅ீ஺௡௔௡௢௦௣௛௘௥௘௦                      (4) 
3. RESULTS AND DISCUSSION 
3.1  Characterization of maghemite nanoparticles 
The chemical structure of maghemite was studied by X-ray diffraction and FTIR. Figure 1 
shows a XRD spectrum of Mag nanoparticles. The diffraction pattern obtained for the 
synthesized maghemite was similar to that described for the standard Ȗ-Fe2O3 crystal (JCPDS 39-
1346). The well-defined X-ray diffraction pattern indicates the formation of highly crystallized 
iron oxide. Ȗ-Fe2O3 particles have cubic unit cells with both octahedrally and tetrahedrally 
coordinated Fe3+ sites (defect spinel structure), and the diffraction planes were attributed in 
Figure 1. The synthesized nanoparticles displayed an average size of 15 nm. 
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Figure 1: XRD patterns of obtained maghemite.
Figure 2 shows the FTIR spectrum of Mag nanoparticles. The broadly band at 3000-3700 cm-1 
is characteristic of hydroxyl (-OH) surface groups of Ȗ-Fe2O3, whereas the peaks at 1400-1600 
cm-1 are due to residual nitrate ions. The bands between 400-600 cm-1 are assigned Fe-O 
stretching and bending vibration mode, respectively of Ȗ-Fe2O3. 24 
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Figure 2: FTIR spectrum of obtained maghemite 
The morphology of Mag nanoparticles was also analyzed by TEM (Figure 3). Mag 
nanoparticles presented a cubic shape with a mean size of about 15 nm, in agreement with the 
XRD calculated size.  
 11
 
Figure 3: TEM image from maghemite nanoparticles. 
3.2  Optimization of Maghemite-loaded PLGA nanospheres 
In order to optimize the preparative process of Mag-loaded PLGA nanospheres and, thus, to 
obtain homogeneous particulates with a maximum of maghemite content, various formulation 
parameters were investigated. Thus, the effect of the PLGA amount, PVA concentration, initial 
amount of MNPs and time of sonication for the emulsification process on the physico-chemical 
characteristics of the resulting nanospheres were evaluated. The effect of some of these 
parameters, such as surfactant concentration, oil-to-water phase ratio, polymer molecular weight, 
polymer concentration and stirring rate have already been studied. 25, 26 However, most of these 
studies have just been applied for the encapsulation of a drug into polymeric nanoparticles rather 
than other nanoparticles in nanospheres.  
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The sonication time at a frequency of 20 kHz were varied in 1, 3 and 5 min. [PLGA] was 
varied in 100, 200 and 400 mg/mL. [PVA] in aqueous phase was varied in 0.5, 1 and 2% and the 
initial ratio of maghemite/PLGA was varied in 0.02, 0.05 and 0.1mg/mg. 
3.2.1  Sonication time during the emulsification step 
The sonication time is of great importance, because if sonication is not applied for sufﬁciently 
long time, the resulting particle size distribution will be broad. The ultrasonication is 
characterized by a complex dynamics of collisions, coalescence, and breakage of droplets, which 
reaches a dynamic equilibrium only after a sufﬁcient time that increases as the emulsiﬁer 
concentration decreases. Afterwards, the droplet size distribution stabilizes, being usually 
characterized by a low polydispersity in the ﬁnal emulsion. 27  
Figure 4 shows the influence of the sonication on the emulsification process of the organic 
phase (containing PLGA and Mag) into the aqueous phase of PVA. As it can be shown, the time 
of sonication influenced the average size, PDI and zeta potential of the resulting nanospheres. 
According to these data, the optimum time of sonication for the preparation of these nanospheres 
was 3 minutes. Under these experimental conditions, the mean size of the resulting nanospheres 
was close to 200 nm and the PDI was around 0.1. Although the literature reports that longer 
sonication times induce the formation of smaller particles, we must consider that the energy 
generated by sonication process may result in an increase of temperature in the area closer to the 
ultrasonic tip, leading to changes in the physical properties of the polymer, resulting in the 
formation of aggregates (like as observed for 5 min of sonication). 28- 29 Despite of the ice bath 
used in the sonication process , the obtained cooling may not be sufficient to maintain a stable 
temperature in the area near the source of energy (ultrasound tip), due to the rate of the 
temperature gradient in the  polymer, resulting the formation of aggregates. Concerning the zeta 
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potential, the time of sonication displayed a low influence in this parameter and small differences 
between the different nanospheres produced were found. In addition, the resulting values of zeta 
potential for the Mag-loaded PLGA nanospheres (in a range between -4.5 and -8 mV) are in 
agreement with previous data reported by other authors. 30- 31 PDI (which indicates the size 
distribution of the nanospheres), with values lower than 0.3 normally are considered 
satisfactory.32 
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Figure 4: Influence of the time of emulsification by sonication on a) the mean hydrodynamic 
size, b) polydispersity index and c) zeta potential (measured at pH 7) of the resulting Mag-loaded 
PLGA nanospheres. Data expressed as mean ± SD (n = 3). Experimental conditions: PLGA: 100 
mg; initial Mag added: 5 mg; PVA concentration:1% w/v. 
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3.2.2  PVA concentration in the aqueous phase 
The amount of emulsifier is probably the parameter that most strongly determines the 
theoretical final particle size. It is well known that an increasing amount of emulsifier leads to a 
decrease of particle size, until a minimum value is reached. 33 While this behavior is general, the 
type of emulsifier is playing an important role, since it is also known that ionic emulsifiers are 
more effective in stabilizing small particles as compared to non-ionic emulsifiers.25 However, 
most of the FDA approved emulsifiers are non-ionic, and we have focused on PVA because it is 
one of the most commonly used emulsifiers in the pharmaceutical industry. In order to 
demonstrate the effect of the emulsifier on the particle size and size distribution in our system, its 
concentration was varied in 0.5, 1 and 2%. Results are shown in Figure 5. 
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Figure 5: Influence of the PVA concentration on a) the mean hydrodynamic size, b) 
polydispersity index and c) zeta potential (measured at pH 7) of the resulting Mag-loaded PLGA 
nanospheres. Data expressed as mean ± SD (n = 3). Experimental conditions: PLGA: 100 mg; 
initial Mag added: 5 mg; Time of sonication: 3 min.  
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When the concentration of PVA in the aqueous phase was 1% w/v, the resulting nanospheres 
displayed the smaller mean size but with the highest homogeneicity. However, with the increase 
in PVA concentration, the viscosity of the external aqueous phase increased in the same way, 
which resulted in size increase due to decrease in the net shear stress. 34, 35 At a high PVA 
concentration (2%), more molecules of PVA may be oriented in organic solvent/water interface 
to reduce efficiently the interfacial tension which resulted in significant increase in the net shear 
stress at a constant energy density during emulsification and promoted the formation of smaller 
emulsion droplets  
PDI values lower than 0.3 are satisfactory and zeta potential variation in the range of -3 and -8 
mV is in agreement with the behavior of the material. 
3.2.3  PLGA concentration 
PLGA concentration in organic phase was varied between 50 and 200 mg/mL, and the 
influence of [PLGA] on the particles size and size distribution was studied. The results are 
shown in Figure 6. As expected, the size of PLGA nanospheres increased by increasing the 
amount of the polymer. This observation is in agreement with previously published reports. 36- 38 
This fact has been related with the increasing viscosity of the dispersed phase (polymer solution), 
resulting in a poorer dispersability of the PLGA solution into the aqueous phase. 37 As a 
consequence, this increased viscosity would induce a high resistance against the shear forces 
during the emulsification process, yielding coarse emulsions, which lead to the generation of 
bigger droplets.  
In addition, by increasing the amount of PLGA, PVA was probably insufficient to cover the 
surface of droplets completely, which caused the coalescence of droplets during the evaporation 
of organic solvent and aggregation of nanoparticles after the removal of organic solvent.33
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Figure 6: Influence of the PLGA concentration on a) the mean hydrodynamic size, b) 
polydispersity index and c) zeta potential (measured at pH 7) of the resulting Mag-loaded PLGA 
nanospheres. Data expressed as mean ± SD (n = 3). Experimental conditions: initial Mag added: 
5 mg; PVA concentration: 1% w/v, Time of sonication: 3 min.  
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3.2.4  Maghemite amount 
The initial maghemite/PLGA ratio was varied in the range 0 to 0.10 mg/mg and the influence 
of this parameter on the size, polydispersibility and zeta potential was evaluated.  Surprinsingly, 
the amount of Mag used to prepare PLGA nanospheres did not influenced significantly the 
physico-chemical properties of the resulting particulates. In all case, the resulting mean sizes 
were around 240 nm with a polydispersity lower than 0.2 and zeta potential data of about -2 to -8 
mV.  
After this optimization study, the following experimental conditions for the preparation of 
PLGA nanospheres were selected: PLGA amount (100 mg), Mag amount (5 mg), PVA 
concentration (1% w/v) and a time of sonication for the emulsification process of 3 minutes. 
Under these experimental conditions the resulting Mag-loaded PLGA nanospheres displayed a 
mean size of 200 nm, a maghemite content of 59 µg per mg nanosphere and an encapsulation 
efficiency of 12% (Table 1). Figures 7 and 8 shows the morphological characterization of these 
nanospheres by SEM and TEM respectively.  
Table 1. Physico-chemical characteristics of PLGA nanospheres. Data expressed as mean ± SD 
(n = 3). Experimental conditions: PLGA amount: 100 mg, initial Mag added: 5 mg; PVA 
concentration: 1% w/v, Time of sonication: 3 min. 
Sample Hydrodinamic 
size (nm) 
PDI Zeta 
Potential 
(mV) 
Mag 
loading 
(µg.mg-1) 
Encapsulation 
efficiency(%) 
PLGA-NE 210 ± 2.1 0.185 ± 0.03 -6.27 ± 0.3 - - 
MagPLGA-NE 202 ± 0.81 0.097 ± 0.04 -7.41 ± 0.3 59 12 
 
Mag-loaded PLGA nanospheres were found to be spherical with an average size of about 200 
nm; similar to the size determined by photon correlation spectroscopy. The maghemite 
 20
nanoparticles encapsulated in nanospheres appeared to be well dispersed inside the PLGA 
nanospheres. 
 
Figure 7: SEM micrograph of Mag-loaded PLGA nanospheres 
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Figure 8: TEM micrograph of Mag-loaded PLGA nanospheres 
In order to investigate the efficiency of the entrapment of magnetic nanoparticles in the 
polymeric nanospheres, we have compared the surface properties of empty PLGA nanospheres 
with Mag-loaded PLGA nanospheres and pure maghemite. Previously, Arias and collaborators 
have proposed the electrophoresis measurement of poly(ethyl-2-cyanoacrylate) nanoparticles 
with a magnetic core as a useful tool for qualitatively checking the efficiency of the magnetite 
coating by the polymer. 39 For this purpose, the zeta potential of empty PLGA nanospheres, 
MagPLGA nanospheres and pure maghemite was assessed as a function of pH in the presence of 
0.3 mM KCl. Figure 9 summarized these results. When the pH of the medium increases from 3 
to 9, the zeta potential of Mag-loaded and empty PLGA nanospheres slightly decreased due to 
the dissociation of negative charge generating groups like carboxylic groups of PLGA polymer. 
13 Then, from pH 9 to 11, the zeta potential of the Mag-PLGA nanospheres was in the same order 
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of magnitude to that of empty PLGA nanospheres. On the contrary, the zeta potential values for 
pure maghemite decreased sharply by increasing the pH conditions. Considering an iron oxide 
surface in contact with water, a fully hydroxylated surface should be expected. The net charge of 
the iron oxide surface is dependent on the protonation/deprotonation of the hydroxyl groups 
when the pH of the solution changes. 40 In any case, these results confirmed that maghemite was 
totally encapsulated in the resulting PLGA nanospheres. These findings are in agreement with 
previous determinations described by Okassa and collaborators working with 
magnetite/maghemite PLGA composite particles. 13  
As observed, for Mag, Mag loaded PLGA nanospheres and empty PLGA nanospheres, the data 
suggest an isoeletric point below pH 2. This small value of isoelectric point for maghemite can 
be due the presence of hydroxyl groups on nanoparticles surface, in agreement with the results 
showed by FTIR spectra, in Figure . 
PLGA nanospheres always bear a net negative surface charge, and our data suggest an 
isoelectric point below pH 2. The electrokinetic properties of Mag loaded PLGA nanospheres is 
in good coincidence with those of pure PLGA, as one would predict in case of an optimum 
coverage. 41 
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Figure 9: Evolution of the zeta potential of particulates as a function of the pH medium. 
4. CONCLUSIONS 
The emulsion-solvent evaporation method allowed the preparation of spherical maghemite-
loaded systems of biodegradable PLGA. The influences of various processing variables on 
particle size, polydispersity and surface zeta potential were systematically assessed. It was 
concluded that formulation variables could be exploited in order to enhance the properties 
previously cited for PLGA nanospheres. Based on the optimal parameters, it was found that 
MagPLGA with expectable properties (average sizes of 200 and 240 nm respectively for 
MagPLGA-NE and MagPLGA-NC and polydispersity lower than 0.3 for both) could be 
obtained. We point out that maghemite (a hydrophilic molecule) could be entrapped into PLGA 
nanospheres and maghemite content (% w/w) respectively of 0.59 and 0.44, consistent with those 
previously reported in the literature. 
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